SOD1 and amyotrophic lateral sclerosis: Dasatinib (Figure 1) showed neuroprotection in SOD1G93A transgenic ALS mice, reducing the cytotoxicity of mutant SOD1 significantly based on cell viability and cell death assays (p < 0.05).